Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447083 · ClinicalTrials.gov registry record · NA
Benefits of Tanning in Fibromyalgia Patients
A NA study of Fibromyalgia Syndrome, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT00447083: Completed NA study of Fibromyalgia Syndrome, sponsored by Wake Forest University.
NCT00447083 is a NA study of Fibromyalgia Syndrome that has completed, run by Wake Forest University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447083, a NA study of Fibromyalgia Syndrome, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
* To establish whether ultraviolet light exposure acutely reduces perceptions of pain in patients with fibromyalgia. * To establish whether a series of UV light exposures has a cumulative effect on fibromyalgia pain.
Primary Outcome
Percentage of exposures that showed pain relief (2 point improvement in Likert scale) in the 11 point Likert scale.
Conditions Studied
Interventions
- DEVICE UVB
- PROCEDURE Non-UVB
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00447083 record still lists
NCT00447083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Fibromyalgia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which UVB is the first listed.
NCT00447083 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00447083 about?
NCT00447083 is a clinical study titled "Benefits of Tanning in Fibromyalgia Patients". * To establish whether ultraviolet light exposure acutely reduces perceptions of pain in patients with fibromyalgia. * To establish whether a series of UV light exposures has a cumulative effect on fibromyalgia pain.
What is the current status of trial NCT00447083?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2005-05. Estimated completion is 2008-09.
What conditions does trial NCT00447083 study?
This clinical trial studies the following conditions: Fibromyalgia Syndrome.
What interventions are being tested in trial NCT00447083?
The interventions under investigation include: UVB (DEVICE), Non-UVB (PROCEDURE).
Who is sponsoring clinical trial NCT00447083?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00447083 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00447083's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia